Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2011-08-23
2011-08-23
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C424S437000
Reexamination Certificate
active
08003616
ABSTRACT:
A composition for treating ear infections in animals includes an antifungal agent, an antibiotic agent, a steroidal anti-inflammatory agent, and an acid dissolved to form a liquid. The acid aids in keeping the steroidal anti-inflammatory agent in solution, and enhances the bactericidal effect of the composition. The method of preparing such composition includes dissolving the antifungal agent, steroidal anti-inflammatory agent, and acid in dehydrated alcohol, dissolving the antibiotic agent in propylene glycol, combining the two solutions together, heating the combination and then cooling the composition. Several drops of the composition are applied at least twice per day to the affected area of the animal's ear.
REFERENCES:
patent: 5753269 (1998-05-01), Groh et al.
patent: 0179583 (1986-04-01), None
Ansel, H.C. Introduction to Pharmaceutical Dosage Forms, 1985, 4th Edition, Lea &Febiger, pp. 337-341.
Troy, D.B., Ed. Remington: The Science and Practice of Pharmacy, 2006. 21st Edition, Lippincott Williams & Wilkins, pp. 1080-1082.
Freedom of Information Summary, ANADA 200-287, GBC Ointment, Phoenix Scientific, Inc., Mar. 28, 2003.
Freedom of Information Summary, NADA 141-177, MOMETAMAX Otic Suspension for Dogs, Schering-Plough Animal Health, Publication date not known, but published prior to Apr. 2003.
“Medical Treatment of Otitis Externa,” Stephen White, Publication date not known, but published before Apr. 2003.
Lecture Notes, Jan. 2003 Dermatology, Daniel O. Morris, D.V.M., District of Columbia Academy of Veterinary Medicine, “Otitis Externa and Media: Diagnosis and management in the age of antibiotic resistance,” Jan. 2003.
Freedon of Information Summary, NADA 140-810, Feb. 3, 1989, Biomed Laboratories, Panavet Ointment.
Product labeling for Otomax® Otic Antibiotic-Steroid, NADA 140-896, Schering-Plough, Publication date not known, but published before Apr. 2003.
Baytril® Otic, product information by Bayer Health Care, Animal Health Division, original publication date not known, but published prior to Apr. 2003.
Jan. 2001 Press Release for Baytril® Otic, dated Jan. 2001.
Baytril® Otic product labeling, Bayer Health Care LLC, Animal Health Divison, publication date not known, but originally published prior to Apr. 2003.
Albert Rory J.
Blaire Michael R.
Cahill Glazer PLC
Jean-Louis Samira
Padmanabhan Sreeni
LandOfFree
Composition for the treatment of ear infections and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition for the treatment of ear infections and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for the treatment of ear infections and method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2774320